Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Trading Update

16 Jun 2010 11:20

RNS Number : 7111N
Plant Health Care PLC
16 June 2010
 



16 June 2010

  

Plant Health Care

 

Trading Update

 

The Company announces that following the notification by one of its key customers of lower than expected sales of the Company's Harpin product in the current growing season resulting in an unanticipated carry-over of inventories, the Company has reduced its expectations of sales of Harpin in 2010 and, in consequence, its expected profit before tax for the year.

 

The Board believes this is a onetime event and the excess inventory will be moved through the customer's existing channels by year end and deliveries of our Harpin product will realign with its expectations beginning with the 2011 marketing year. Whilst it is still early in the season and therefore difficult to forecast uptake the Board considers that it would be prudent to anticipate that the level of sales into this channel in 2010 may be 50% or more below the previously expected levels. Accordingly, whilst the Board will provide further updates as soon as possible, it is likely that it will not have much visibility on sales until the latter part of the year.

 

The Board believes the long term prospects for this channel remain as strong as previously expected and with potentially new markets available sales will recover to previously forecasted levels. The Board also confirms that discussions with other potential licencees for Harpin continue to progress well and remains confident of achieving further agreements during the year for application on other crops.

 

It is expected that the interim results will be released by early September at which time a further update will be provided as to the Board's expectations for the current year.

 

-Ends-

 

 

For further information please visit www.planthealthcare.com or contact:

 

Plant Health Care

Evolution Securities Limited

Tavistock Communications

John Brady

Chief Executive

Tim Worlledge(Nomad)

/Tim Redfern (Corporate Broker)

Jeremy Carey/Matt Ridsdale

17 -19 June

Tel: 020 7920 3150

Thereafter: 001 603 525 3702

Tel: +44 (0) 20 7071 4300

Tel: +44 (0) 20 7920 3150

 

 

 

 

 

 

 

Notes to Editors:

 

About Plant Health Care

 

About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately [90] employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUNARRRKANAAR
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.